ABT-199 partners with azacitidine to contest myeloid malignancies

Research output: Contribution to journalArticleOther

Original languageEnglish
Pages (from-to)8 - 9
Number of pages2
JournalLeukemia and Lymphoma
Volume56
Issue number1
DOIs
Publication statusPublished - 2015

Cite this

@article{d2606cb42c3442948f2c2dfad0d831f7,
title = "ABT-199 partners with azacitidine to contest myeloid malignancies",
author = "Andrew Wei",
year = "2015",
doi = "10.3109/10428194.2014.919638",
language = "English",
volume = "56",
pages = "8 -- 9",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor & Francis",
number = "1",

}

ABT-199 partners with azacitidine to contest myeloid malignancies. / Wei, Andrew.

In: Leukemia and Lymphoma, Vol. 56, No. 1, 2015, p. 8 - 9.

Research output: Contribution to journalArticleOther

TY - JOUR

T1 - ABT-199 partners with azacitidine to contest myeloid malignancies

AU - Wei, Andrew

PY - 2015

Y1 - 2015

UR - http://www.tandfonline.com/doi/full/10.3109/10428194.2014.919638

U2 - 10.3109/10428194.2014.919638

DO - 10.3109/10428194.2014.919638

M3 - Article

VL - 56

SP - 8

EP - 9

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1

ER -